Kendall Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
Kendall Capital Management's COLL Position: Q3 2026 in Review
Kendall Capital Management reduced its Collegium Pharmaceutical (COLL) stake by 18% in Q3 2026, selling an estimated $180K and leaving 28,560 shares worth $623K. The position accounts for 0.1% of the portfolio, ranked #153.
Kendall Capital Management first reported a position in COLL in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.26M in Q2 2026. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.
- Kendall Capital Management held 28,560 shares of Collegium Pharmaceutical worth $623K as of Q3 2026.
- Kendall Capital Management sold 6,170 Collegium Pharmaceutical shares in Q3 2026, an estimated $180K.
- Collegium Pharmaceutical made up 0.1% of Kendall Capital Management's portfolio in Q3 2026, its #153 holding.
- Kendall Capital Management first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
- Kendall Capital Management's Collegium Pharmaceutical position peaked at $1.26M in Q2 2026.
- 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.
Based on Kendall Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.